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The fibroblast growth factor (FGF) family polypeptides play key roles in promoting tissue
regeneration and repair. FGF5 is strongly up-regulated in Schwann cells of the peripheral
nervous system following injury; however, a role for FGF5 in peripheral nerve regeneration
has not been shown up to now. In this report, we examined the expression of FGF5 and
its receptors FGFR1-4 in Schwann cells of the mouse sciatic nerve following injury, and
then measured the effects of FGF5 treatment upon cultured primary rat Schwann cells.
By microarray and mRNA sequencing data analysis, RT-PCR, qPCR, western blotting
and immunostaining, we show that FGF5 is highly up-regulated in Schwann cells of the
mouse distal sciatic nerve following injury, and FGFR1 and FGFR2 are highly expressed
in Schwann cells of the peripheral nerve both before and following injury. Using cultured
primary rat Schwann cells, we show that FGF5 inhibits ERK1/2 MAP kinase activity but
promotes rapid Schwann cell migration and adhesion via the upregulation of N-cadherin.
Thus, FGF5 is an autocrine regulator of Schwann cells to regulate Schwann cell migration
and adhesion.
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INTRODUCTION
The fibroblast growth factor (FGF) family includes 22 structurally related polypeptides
that are highly conserved in mammals (Beenken and Mohammadi, 2009; Ornitz and Itoh,
2015). FGF1-22 proteins bind with high affinity to four FGF receptors, FGFR1-4, and
FGFR1-4 activation has been implicated in multiple biological processes in mammals including
cell proliferation and differentiation during development and tissue repair (Ornitz and Itoh,
2015). Mutations in FGF or FGFR genes cause developmental and genetic diseases in many
different tissue types (Beenken and Mohammadi, 2009; Ornitz and Itoh, 2015). Numerous
studies have also reported roles for FGFs in tissue regeneration and repair, underlying the
importance of FGF-FGFR signaling in tissue homeostasis (Nunes et al., 2016; Charoenlarp
et al., 2017; Maddaluno et al., 2017). The activation of a specific FGF-FGFR signaling and
subsequent biological activities depends on the spatial and temporal expression pattern of
each FGF ligand and their receptors (Beenken and Mohammadi, 2009; Ornitz and Itoh, 2015).
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We are interested in the molecular mechanism of peripheral
nerve regeneration following injury, and among all the FGFs,
FGF5 is highly up-regulated in the distal nerve in response to
injury (Moscoso et al., 1998; McGeachie et al., 2001; Scarlato
et al., 2001); this striking increase suggests a role for FGF5 in the
regulation of peripheral nerve repair.
The FGF5 gene was first isolated as a human oncogene
by a DNA rearrangement accompanying the transfection of
fibroblasts with human tumor DNA (Zhan et al., 1987, 1988).
FGFs can be arranged into seven subfamilies based on a
phylogenetic analysis, and FGF5 resides in the FGF4 family,
which is comprised of FGF4, FGF5, and FGF6 (Ornitz and
Itoh, 2015). All members of this subfamily are secreted proteins
with cleavable N-terminal signal peptides that mediate biological
responses as extracellular proteins by binding to and activating
FGFR1-4. Despite high expression of FGF5 in both embryonic
and adult tissues (Haub et al., 1990; Haub and Goldfarb, 1991),
FGF5 knockout mice are viable (Hébert et al., 1994) and the
only phenotype that has been observed in FGF5 knockout
mice was abnormally long hair (Hébert et al., 1994). This
phenotype is identical to homozygous mice for the spontaneous
mutation angora (go) mice (Hébert et al., 1994). Crossing of
FGF5 knockoutmice and gomutationmice failed to complement
the long hair phenotype, resulting in the identification of the go
mutant as a mutant allele of FGF5 (Hébert et al., 1994).
FGF5 is detectable in adult rat skeletal muscle and its
expression increases in skeletal muscle following denervation
(Hughes et al., 1993; McGeachie et al., 2001). In vitro analysis
showed that FGF5 could promote the survival of embryonic
motor neurons, therefore, FGF5 has been proposed as a muscle-
derived regulator of motor axon regeneration (Hughes et al.,
1993). However, in vivo studies have failed to show defects in
muscle reinnervation in FGF5 null mice (Moscoso et al., 1998).
Furthermore, in vivo studies in go homozygotes mice not only
found that endogenous FGF5 is not transported in motor axons
but also failed to reveal any loss of motoneurones (McGeachie
et al., 2001). Later studies confirmed that FGF5 protein
was expressed in the terminal and non-terminal Schwann
cells but not in muscle fibers (McGeachie et al., 2001).
Scarlato et al. (2001) also showed that nerve injury resulted
in an increase of FGF5 in the Schwann cells of the distal
nerve. Schwann cells have been shown to express FGFR1–3
(Meisinger and Grothe, 1997; Grothe et al., 2006; Furusho
et al., 2009). This raised the possibility that FGF5 could be
an autocrine regulator of Schwann cell behavior during nerve
regeneration (McGeachie et al., 2001; Scarlato et al., 2001),
however, the effects of FGF5 upon Schwann cells have not
been examined.
In this report, we first systematically examined the expression
of FGF5 and FGFR1-4 expression in Schwann cells upon
injury, and then tested the effects of FGF5 on cultured primary
rat Schwann cells. We show that FGF5 ligand is strongly
up-regulated in mouse Schwann cells following injury, and
FGFR1 and FGFR2 are highly expressed in Schwann cells of the
mouse distal sciatic nerve. Using cultured primary rat Schwann
cells, we show that FGF5 treatment rapidly promotes Schwann
cell migration and adhesion via the upregulation of N-cadherin,
identifying an autocrine function for FGF5 upon Schwann cells
that regulates Schwann cell migration and adhesion.
MATERIALS AND METHODS
Animals and Peripheral Nerve Surgery
All work involving animals was carried out according to Home
Office regulation under the UK Animals Scientific Procedures
Act 1986. Ethical approval for all experiments was granted by
Plymouth University Animal Welfare and Ethical Review Board.
Sprague–Dawley rats and C57BL/6 mouse breeding pairs were
purchased from Charles River UK limited. PLP-GFP mice were
described before Mallon et al. (2002) and Dun et al. (2019). All
animals were housed in a controlled laboratory environment
(temperature 22± 2◦C, humidity 50–60%, 12-h light/dark cycle).
All animals were fed with standard rodent diet and water
added ad libitum. Two-month-old male and female mice were
randomized and anesthetized with isoflurane, the right sciatic
nerve was exposed and transected at approximately 0.5 cm
proximal to the nerve trifurcation site and no re-anastomosis
of the severed nerve was performed. The overlying muscle
was sutured and the skin was closed with an Autoclip
applier. All animals undergoing surgery were given appropriate
post-operative analgesia, 0.05% bupivacaine solution, topically
applied above the muscle suture before applying surgical clips.
Meloxicam (5 mg/kg) injection was given just before recovery
from anesthetic. All animals undergoing surgery were given
nesting material and cage enrichment to minimize the risk
of autotomy and monitored daily. At the indicated time
points post-surgery for each experiment described, animals were
euthanized humanely using carbon dioxide following UK Home
Office regulations.
FGF5, Primary and Secondary Antibodies
Recombinant Human FGF5 (R&D, 237-F5), anti-FGF5 antibody
(Abcam, ab88118), anti-FGFR1 antibody (Abcam, ab10646),
anti-FGFR2 antibody (Abcam, ab10648), CD206 antibody
(R&D, AF2535), Phospho-ERK1/2 antibody (Cell Signaling,
#9101), Total-ERK1/2 antibody (Cell Signaling, #9102),
N-cadherin (Becton-Dickinson, 610920) and GAPDH antibody
(EMD Millipore, MAB374) were used. Hoechst and species-
specific secondary antibodies conjugated with Alexa Fluor
488 or 568 dyes were purchased from Invitrogen. Horseradish
peroxidase (HRP) conjugated secondary antibodies for western
blotting were purchased from Sigma.
mRNA Purification, cDNA Synthesis,
RT-PCR and qRT-PCR
Total mRNA was extracted using a miRNeasy Mini Kit (Qiagen,
217004) and the first-strand cDNA was synthesized with
M-MLV reverse transcriptase (Promega, M368) using random
hexamer primers (Promega, C1181). RT-PCR was performed
in the G-Storm GS4M, qRT-PCR was performed in the PCR
LightCycler480 Real-Time PCR Instrument (Roche Applied
Science) using SYBR Green I Master with the primers showing
in Table 1. Crosspoint (Cp) values were calculated by using
the software of the LightCycler480 Real-Time PCR Instrument.
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TABLE 1 | Sequence information of forward and reverse primers.
Primers Forward: 5′—3′ Reverse: 5′—3′ Size
FGF5 CCCACGAAGCCAGTGTGTTA ATCGCGGACGCATAGGTATT 199 bp
FGFR1 GACTCTGGCCTCTACGCTTG TGGGGATGTCCAGTAGGGAG 194 bp
FGFR2 CACGACCAAGAAGCCAGACT CTCGGCCGAAACTGTTACCT 94 bp
FGFR3 GTGGTGGCAGCTGTGATACT TTAAGCGGGAAGCGAGAGAC 95 bp
FGFR4 GGAAGGTGGTCAGTGGGAAGT CTGCTCCAGGATTGGGGCTA 164 bp
GAPDH AAGGTCATCCCAGAGCTGAA CTGCTTCACCACCTTCTTGA 222 bp
Relative mRNA levels were calculated by the 2(-Delta Delta
C(T)) method (Livak and Schmittgen, 2001) using GAPDH as
a reference gene for normalization. All reactions were carried out
in triplicate for statistical analysis.
Schwann Cell Culture and FGF5 Treatment
Schwann cells were prepared from the sciatic nerve and brachial
plexus of day three Sprague–Dawley rats as previously described
(Brockes et al., 1979; Dong et al., 1997; Maurel, 2018). Schwann
cells were cultured in six well plates with low glucose (1 g/ml)
DMEM containing 10% fetal bovine serum (FBS), 10 ng/ml
NRG-1 (R&D, Cat No. 396-HB-050) and 2 µM forskolin
(Sigma, Cat No. 344270). For the ERK activation experiment,
Schwann cells were starved in low glucose DMEM containing
1% FBS overnight. The following morning cells were treated
with 10 ng/ml FGF5 and lysed after 0, 5, 10, 20, 30, and
60 min of treatment. For extended FGF5 treatment, Schwann
cells were changed to low glucose DMEM containing 10% FBS
16 h before FGF5 treatment, and the following morning treated
with 5 ng/ml FGF5 and images were taken every 2 h on a
LeicaIM8 microscope.
Immunohistochemistry and
Immunocytochemistry
Sciatic nerve samples were dissected out and fixed overnight in
4% paraformaldehyde (in PBS, PH7.2) at 4◦C. The samples were
then washed in PBS (3× 10 min) and dehydrated in 30% sucrose
(in PBS) overnight at 4◦C. Subsequently, samples were embedded
in OCT medium and sectioned on a cryostat at a thickness of
12 µm. Schwann cells cultured on coverslips were fixed in 4%
paraformaldehyde at 4◦C for 15 min and then washed in PBS
(3 × 10 min). The sections or cells were permeabilized with
0.25% Triton X-100 plus 1% bovine serum albumin (BSA) in
PBS for 45 min and then blocked with blocking buffer (3% BSA
plus 0.05% Triton X-100 in PBS) for 1 h at room temperature.
The sections or cells were incubated with primary antibodies
(1:100 diluted in blocking buffer) overnight at 4◦C. The next day,
sections were washed with PBS (3× 10 min) and then incubated
with species-specific secondary antibodies plus Hoechst dye
(1:500 diluted in blocking buffer) for 1 h at room temperature.
Finally, sections were washed with PBS (3 × 10 min) and
mounted with Citifluor (Agar Scientific, R1320) for imaging with
a Leica SPE confocal microscope (Dun et al., 2019).
Western Blot
Nerve samples were dissected out with similar size and directly
sonicated into 1× SDS loading buffer. Cells were lysed in 200 µl
of radio-immunoprecipitation assay (RIPA) buffer (50 mM
Tris-HCl, pH 7.4, 0.1% SDS, 1% NP-40, 150 mM NaCl,
1 mM ethylenediaminetetraacetic acid (EDTA), 0.5% sodium
deoxycholate) plus phosphatase inhibitor cocktails (1:100, Santa
Cruz Biotechnology, sc-45045 and sc-45065). Cell lysates were
spun down at 16,000× g for 15 min at 4◦C. The supernatant
was transferred to new 1.5 ml microcentrifuge tubes and the
protein concentration was determined using the PierceTM BCA
Protein Assay Kit. An appropriate volume of samples containing
20 µg of protein was added to the 4× sample buffer. Proteins
were separated on 10% or 12% SDS polyacrylamide running
gels and transferred onto a polyvinylidene fluoride (PVDF,
0.45 µm) transfer membrane using the wet transfer method.
Membranes were blocked in 5% fat-free milk in TBST (Tris-
buffered saline plus 0.1% Tween-20) for 1 h at room temperature.
Primary antibodies were diluted (1:500) in 5% milk (in TBST)
and the membranes were incubated in primary antibodies
overnight at 4◦C. The next day, membranes were washed in TBST
(3× 10min) and then incubated withHRP conjugated secondary
antibody (Sigma, 1:5,000 in 5% milk, TBST) for 1 h at room
temperature. After three TBST washes (10 min each), Pierce ECL
western blotting substrate was added onto the membrane and
incubated for 5 min to develop the chemiluminescent signal.
Amersham HyperfilmTM ECL films were used to capture the
intensity of the chemiluminescent signal. Exposed films were
then developed in a Compact X4 automatic processor. The
intensity of protein bands was quantified using the free ImageJ
software available from https://imagej.nih.gov/ij/.
Cell Viability Assay
Culturing medium in the 6-well plate was carefully removed
and Schwann cells were washed once with 1 ml PBS. Schwann
cells were then stained with a 1.5 ml trypan blue solution
(0.4%, Thermo Fisher Scientific, Cat No.:15250061; Strober,
2015; Lebeau et al., 2019). After 2 min staining, cells were rinsed
twice with 1 ml PBS and a final 1.5 ml PBS was added into the
wells for immediately imaging using a LeicaIM8 microscope.
Statistical Analysis
The samples for Western blotting and qRT-PCR were prepared
by grouping three nerves from three different mice together
for each time point to create a pooled sample as n = 1, and
then repeated the process using another six animals to reach
n = 3. Therefore, we have used pooled biological replicates for
the repetition of these experiments. Statistical significance was
analyzed using the Student’s t-test by comparing the test groups
with the control groups. Data are represented in the figures as
mean value± SEM.
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RESULTS
Analysis of FGF5 Up-Regulation in
Schwann Cells and in the Mouse Distal
Sciatic Nerve With Published Microarray
and mRNA Sequencing Data Sets
Previously, we studied the gene expression profile of cultured
rat primary Schwann cells by microarray analysis (Dun
et al., 2019). Analyzing the expression of all FGF family
members in our microarray data (GSE123915) showed that
FGF5 has the highest expression level in cultured rat primary
Schwann cells (Figure 1A). Recently, Clements et al. (2017)
studied in vivo Schwann cell mRNA expression by an mRNA
sequencing technique with Schwann cells isolated from intact
and 7 days injured mouse sciatic nerve (GSE103039). Analyzing
their mRNA sequencing data showed that FGF5 mRNA is
up-regulated greater than 50-fold in Schwann cells following
injury (Figure 1B). We further analyzed two published
microarray data sets, GSE22291 and GSE74087, in the Gene
Expression Omnibus (GEO1) that have studied the time course
of gene expression in adult mouse distal sciatic nerve at 3,
7 and 14 days post-injury (Barrette et al., 2010; Pan et al., 2016).
Although FGF5 fold changes have large differences between two
data sets of GSE22291 and GSE74087, analyzing both data sets
showed that FGF5 is highly up-regulated in the mouse distal
sciatic nerve at 3, 7 and 14 days following injury (Figures 1C,D).
Validation of FGF5 Increase in Schwann
Cells of the Mouse Distal Sciatic Nerve
Following Injury
Next, we validated FGF5 mRNA up-regulation in mouse distal
sciatic nerve following injury. RT-PCR results showed weak
FGF5 expression on intact adult mouse sciatic nerve with an
upregulation in the distal sciatic nerve at 7 days following
injury (Figure 2A). Quantitative PCR showed that FGF5 was
significantly up-regulated from day 4 to day 14 in the mouse
distal sciatic nerve compared to intact control contralateral nerve
(Figure 2D). On day 4 after injury, FGF5 mRNA showed an
almost 90-fold up-regulation compared to uninjured controls,
with an even higher increase seen (>300) at 7 days and with
a greatly increased expression at days 10 and 14 (Figure 2D).
The FGF5 mRNA fold changes from our qPCR data show high
similarity with the microarray data set GSE74087 (Figure 1D).
Consistent with the results of the FGF5 mRNA expression
pattern, FGF5 protein measurement by Western blotting is low
in the intact mouse sciatic nerve and is highly up-regulated
in the distal sciatic nerve following injury (Figures 2B,C).
Our western blot results also showed that cultured rat
primary Schwann cells express high levels of FGF5 protein
(Figures 2B,C). Staining FGF5 on cultured rat primary Schwann
cells revealed that FGF5 shows a punctate expression pattern
in Schwann cell cytoplasm (Figure 2E), a typical staining
pattern for secreted polypeptides (van Lieshout et al., 1995;
Whim and Moss, 2001).
1http://www.ncbi.nlm.nih.gov/geo/
To confirm the expression of FGF5 in Schwann cells of
the sciatic nerve, we stained FGF5 on intact and injured
sciatic nerve sections from PLP-GFP mice, which label Schwann
cells GFP-positive (Mallon et al., 2002; Carr et al., 2017;
Dun et al., 2019). Staining of FGF5 on intact sciatic nerve
transverse sections from PLP-GFP mice showed that FGF5 could
be easily detected in the cell bodies of myelinating Schwann
cells (Figures 3A–D, indicated by white arrows). Staining for
FGF5 on injured nerves of PLP-GFP mice at 7 days post-injury
revealed that Schwann cells are the principal cells expressing
FGF5 (Figures 3E–H, indicated by white arrows). Previously,
McGeachie et al. (2001) found that macrophages in skeletal
muscle also express FGF5 after denervation. Resident and
infiltrated macrophages are an important cell type in the distal
nerve promoting peripheral nerve regeneration following injury
and comprise 20% of cells in the distal sciatic nerve (Stierli
et al., 2018). Ydens et al. (2012) showed that the majority
of macrophages in the distal nerve show an M2 phenotype.
Therefore, we double stained FGF5 with an M2 macrophage
marker CD206 on distal sciatic nerve longitudinal sections from
C57BL/6 mice at 7 days post-injury. Our staining showed that
FGF5 is not expressed in M2 macrophages of the distal sciatic
nerve (Figures 3I–L, indicated by white arrows).
FGF5 Receptors Expression in Schwann
Cells of the Mouse Distal Sciatic Nerve
Following Injury
The FGF family molecules can bind to FGFR1-4 and regulate
migration, proliferation, differentiation, survival, and metabolic
activities in a wide variety of cells (Ornitz and Itoh, 2015).
To understand the role of FGF5 in Schwann cells during
peripheral nerve regeneration, we used RT-PCR to detect
FGFR1-4 expression in intact mouse sciatic nerve, and in
the distal sciatic nerve following injury. Results showed that
FGFR1–3 mRNAs are present in the intact and injured mouse
sciatic nerve but FGFR4 is hardly detectable both before
and after injury (Figure 4A). FGFR1 appears at the highest
level of expression in the mouse sciatic nerve both before
and after injury. FGFR2 is also expressed, but the expression
of FGFR3 is very weak (Figure 4A). We next analyzed
FGFR1-4 mRNA expression in Schwann cells isolated from
intact and 7 days injured mouse sciatic nerve with the data
set of GSE103039 (Clements et al., 2017). Consistent with
our RT-PCR results, FGFR1–3 mRNA could be detected in
isolated Schwann cells by mRNA sequencing both before and
after injury but FGFR4 mRNA was undetectable (Clements
et al., 2017). Analyzing the mRNA sequencing data of the
Clements dataset also showed that Schwann cells in the
mouse distal sciatic nerve express the highest levels of FGFR1,
followed by FGFR2 and then FGFR3 (Figures 4B,C). We
also analyzed FGFR1–3 expression on cultured rat primary
Schwann cells with our microarray data set GSE123915 (Dun
et al., 2019). In agreement with the mRNA sequencing data of
FGFR1–3 expression levels in vivo for Schwann cells, relative
expression levels of FGFR1>FGFR2>FGFR3 were observed
(Figure 4D).
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FIGURE 1 | Analysis of fibroblast growth factor 5 (FGF5) up-regulation in Schwann cells and in the mouse distal sciatic nerve from published microarray and mRNA
sequencing data sets. (A) Analyzing the expression of all FGFs in cultured rat primary Schwann cells with our microarray data GSE123915, FGF5 has the highest
expression level in cultured rat primary Schwann cells. (B) Analyzing FGF5 mRNA up-regulation in Schwann cells of the distal mouse sciatic nerve 7 days post-injury
with the mRNA sequencing data set GSE103039, FGF5 mRNA level is 51.5-fold upregulated in Schwann cells compared to the uninjured nerve. (C,D) Analyzing
microarray data sets GSE22291 and GSE74087 showing FGF5 mRNA up-regulation in the mouse distal sciatic nerve at 3, 7, and 14 days post-injury.
***Indicates p < 0.001.
FIGURE 2 | Validation of FGF5 up-regulation in mouse distal sciatic nerve and cultured Schwann cells. (A) RT-PCR showing weak FGF5 mRNA expression in
control sciatic nerve and strong expression in the distal sciatic nerve at 7 days post-injury. (B) Western blot detecting weak FGF5 protein expression in control mouse
sciatic nerve and strong up-regulation in distal sciatic nerve at 4 and 7 days post-injury. Cultured rat primary Schwann cells express a high level of FGF5 protein.
(C) Quantification of three independent FGF5 western blot results. (D) Quantitative PCR validates FGF5 mRNA up-regulation in the mouse distal sciatic nerve at 4, 7,
10, and 14 days post-injury; intact contralateral sciatic nerves used as control samples. (E) Staining of FGF5 on cultured rat primary Schwann cells shows punctate
FGF5 expression pattern in Schwann cell cytoplasm. HO: Hoechst. Scale bar in (E) 20 µm. ***Indicates p < 0.001.
Next, we immunolabeled for FGFR1 and FGFR2 on intact
and injured sciatic nerve sections from PLP-GFP mice. Staining
for FGFR1 and FGFR2 on intact sciatic nerve transverse
sections showed that FGFR1 and FGFR2 are both primarily
expressed on Schwann cells of the sciatic nerve (Figure 5).
Staining of FGFR1 and FGFR2 on distal sciatic nerve transverse
sections from PLP-GFP mice at 7 days post-injury revealed
that Schwann cells are the principal cells expressing FGFR1
(Figures 5E–H) and FGFR2 (Figures 5M–P) in the distal
sciatic nerve.
FGF5 Regulates Schwann Cell Migration
and Adhesion
Initially, FGF5 was suggested to have a function in promoting
the survival of motoneurons (Hughes et al., 1993), although
a loss of motoneurons in go mutation homozygous mice was
not observed (McGeachie et al., 2001). A regeneration defect of
motor axon reinnervation was also not observed in go mutation
homozygousmice (Moscoso et al., 1998). Based on the expression
of FGFR1 and FGFR2 on Schwann cells, FGF5 has been
suggested as an autocrine regulator for Schwann cell proliferation
and survival during Wallerian degeneration (McGeachie et al.,
2001; Scarlato et al., 2001), but this possible FGF5 function
remains to be examined. FGF-mediated cell proliferation and
survival are primarily triggered by the activation of downstream
mitogen-activated protein kinase (MAPK) signaling pathways
(Ornitz and Itoh, 2015; Tian et al., 2019). Therefore, we
treated cultured rat primary Schwann cells with FGF5 and
examined ERK1/2 activation by western blot. To our surprise,
FGF5 treatment failed to activate ERK1/2 in Schwann cells
but instead inhibited the basal level of ERK1/2 activity
(Figures 4E,G).
Having not observed ERK1/2 activation in Schwann cells
up to 1 h following FGF5 treatment, we extended the time
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FIGURE 3 | Staining of FGF5 in intact and 7 days post-injury mouse sciatic nerve. (A–D) Staining of FGF5 on intact sciatic nerve transverse sections from PLP-GFP
mice. FGF5 can be seen in the cell bodies of myelinating Schwann cells (indicated by arrows in panel C). (E–H) Staining of FGF5 on distal sciatic nerve transverse
sections from PLP-GFP mice at 7 days post-injury; Schwann cells are the principal cells expressing FGF5 in the distal sciatic nerve. (I–L) Double staining of
FGF5 with the macrophage marker CD206 on longitudinal sections of the distal sciatic nerve from C57BL/6 mice at 7 days post-injury; FGF5 is not expressed in
macrophages of the distal sciatic nerve. HO: Hoechst. Scale bar 20 µm.
of FGF5 treatment to examine FGF5 effects on Schwann cells.
Interestingly, we observed rapid Schwann cell movement after
2 h of treatment and increased cell-cell adherence (Figure 6B).
Following FGF5 treatment, Schwann cells could be observed
moving toward each other and forming distinct clusters, in a
time-dependent manner with Schwann cell processes connecting
adjacent clusters (Figure 6). The Schwann cell cluster formation
indicated that FGF5 not only regulates rapid Schwann cell
movement but also strongly enhances Schwann cell adhesion.
At 6 h of treatment, lager Schwann cell clusters could be
observed and more larger space appeared in the wells of six-well
plates, Schwann cells within the same cluster could be observed
growing on top of each other. At this stage, some individual
Schwann cells could be seen but they are sending a long
process connecting with surrounding clusters (Figure 6D). By
the time of 8 h of treatment, small clusters have moved toward
each other and formed even larger clusters. The Schwann cell
processes connecting different clusters still could be seen, but
it is rare to see individual Schwann cells in space (Figure 6E).
It appears that the connecting processes could communicate
between cells and promote adjacent clusters moving together
to form larger clusters. At 10 h of treatment, all the clusters
moved together and formed three or four big clusters in each
well of the six-well plate (Figure 6F). We further performed
trypan blue exclusion staining to test the cell viability because
most cell clusters detached from the wells after 10 h of
FGF5 treatment. The staining showed that Schwann cells are
alive although they formed clusters and detached from the wells
(Figures 6G–I).
Previous studies showed that N-cadherin is upregulated in
Schwann cells following peripheral nerve injury and N-cadherin
is a key adhesion molecule that regulates Schwann cell migration
and adhesion (Wanner and Wood, 2002; Parrinello et al., 2010;
Clements et al., 2017; Roberts et al., 2017). We then examined
N-cadherin expression in Schwann cells by western blot
following FGF5 treatment. The western blot results revealed that
N-cadherin expression is significantly upregulated in Schwann
cells after 4, 6, 8, and 10 h of FGF5 treatment (Figures 4F,H).
Thus, we identified an FGF5 autocrine function regulating
Schwann cell migration and adhesion via the upregulation of
N-cadherin.
DISCUSSION
The FGF family consists of 22 structurally related molecules
that bind with high affinity to four FGF receptors (FGFR1-4).
Activation of FGF-FGFR signaling and subsequent biological
activities not only depend on the spatial and temporal expression
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FIGURE 4 | Expression of FGFR1-4 in intact and injured mouse sciatic nerve. (A) RT-PCR showing FGFR1-4 mRNA expression in control and 7 days post-injury
mouse sciatic nerve. (B) Data showing expression of FGFR1–3 mRNA at 7 days post-injury from mRNA sequencing data set GSE103039. (C) Fold difference of
FGFR1 and FGFR2 against FGFR3 analyzed with the mRNA sequencing data set GSE103039. (D) The expression value of FGFR1–3 in cultured Schwann cells in
our microarray data set GSE123915. (E) Western blot results showing that FGF5 inhibits the basal levels of ERK1/2 activity in cultured rat primary Schwann cells. (F)
Western blot results showing that FGF5 significantly upregulates N-cadherin expression in Schwann cells after 4, 6, 8, and 10 h treatment. (G) Quantification of three
independent western blot results for ERK1/2 inhibition by FGF5. (H) Quantification of three independent western blot results for N-cadherin upregulation. ∗∗∗ Indicates
p < 0.001.
pattern of FGFs but also the expression patterns of the FGFR1-
4 receptors (Ornitz and Itoh, 2015; Tian et al., 2019). Numerous
recent studies have reported roles for the FGFs in tissue and
organ regeneration, such as FGF2, FGF4, and FGF8 for the
limb/digit regeneration, FGF1 and FGF8 for lens regeneration,
FGF2 for nervous system regeneration and FGF7 for skin and
intestinal regeneration (Nunes et al., 2016; Maddaluno et al.,
2017). Among all the FGFs, FGF1 and FGF2 have been studied
in peripheral nerve regeneration. FGF1 expression is restricted
largely to neurons, therefore levels of FGF1 protein fall in the
distal nerve following injury and axon degradation (Eckenstein
et al., 1991; Ishikawa et al., 1992). FGF-2, in contrast, is
expressed by Schwann cells both before and after peripheral
nerve injury (Meisinger and Grothe, 1997; Grothe et al.,
2006; Furusho et al., 2009). Overexpression of FGF2 promoted
peripheral nerve regeneration and increased Schwann cell
proliferation, axonal regrowth, and re-myelination (Jungnickel
et al., 2006). Additionally, repairing of a nerve gap following
transection with a silicone tube containing FGF2 overexpressing
Schwann cells also promoted peripheral nerve regeneration
(Allodi et al., 2014).
So far, the best-established biological effect of FGF5 is
as a paracrine inhibitor of proliferation of hair outer root
sheath cells (Pethö-Schramm et al., 1996; Higgins et al., 2014).
In humans, FGF5 is expressed within the upper outer root
sheath cells of hair follicles, with FGF5 mutation resulting
in excessively long eyelashes (Higgins et al., 2014). Global
FGF5 knockout mice are viable and have an abnormally long
hair phenotype, which is also seen in many other mammalian
species (Hébert et al., 1994). This phenotype is identical to
that of mice homozygous for the spontaneous mutation angora
(go) mice. FGF5 knockout mice and go mutations cross-
breeding failed to rescue each other’s long hair phenotype,
resulting in the identification of exon 1 deletion of FGF5 DNA
in go mutant mice. Thus, go is a mutant allele of FGF5
(Hébert et al., 1994). The long hair phenotype has also been
reported in other species. Genome-wide association studies in
dogs identified a mutation in FGF5 that is associated with
hair length (Housley and Venta, 2006; Dierks et al., 2013).
A missense mutation in FGF5 was found in longhaired cats
(Drögemüller et al., 2007; Kehler et al., 2007). The long-hair
phenotype of FGF5 gene knockout or mutations has also been
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FIGURE 5 | Staining of FGFR1 and FGFR2 in intact and injured mouse sciatic nerve of PLP-GFP mice. (A–D) Staining of FGFR1 on intact sciatic nerve transverse
sections from PLP-GFP mice. (E–H) Staining of FGFR1 on distal sciatic nerve transverse sections from PLP-GFP mice at 7 days post-injury; Schwann cells are the
principal cells expressing FGFR1 in the distal sciatic nerve. (I–L) Staining of FGFR2 on intact sciatic nerve transverse sections from PLP-GFP mice. (M–P) Staining of
FGFR2 on distal sciatic nerve transverse sections from PLP-GFP mice at 7 days post-injury, Schwann cells in the distal sciatic nerve express FGFR2. HO: Hoechst.
Scale bar 20 µm.
reported in sheep, goat, donkey, hamster and guinea pigs
(Legrand et al., 2014; Wang et al., 2015, 2016; Yoshizawa
et al., 2015, 2016; Hu et al., 2017; Li et al., 2017; Yu et al.,
2018). These findings provide evidence that FGF5 functions
as an inhibitor of hair elongation, thus identifying one of the
FGF5 key functions.
Northern blot analysis of total RNA obtained from hindlimb
skeletal muscle of embryonic, postnatal and adult rats showed
that FGF5 mRNA is expressed in rat skeletal muscle during
the period of embryonic motoneuron death as well as in the
adult skeletal muscle (Hughes et al., 1993). Therefore, the
potential role of FGF5 functioning as a target-derived trophic
factor for spinal motoneurons has been examined in vitro.
In vitro experiments showed that recombinant FGF5 promoted
the survival of cultured embryonic chick motoneurons. Extracts
from rat skeletal muscle also promoted the survival of
cultured embryonic chick motoneurons and the motoneuron
survival activity of rat skeletal muscle extracts could be
immunoprecipitated using an antiserum to FGF5 (Hughes et al.,
1993). Lindholm et al. (1994) also reported that FGF5 has
neurotrophic activity on cultured rat septal cholinergic and
raphe serotonergic neurons. Above in vitro results suggested
that FGF5 might act as a target-derived trophic factor for
motoneurons. However, in vivo studies using the double-ligation
technique has revealed that endogenous FGF5 is not transported
in motor axons. Furthermore, stereological estimates of the
number of motoneurons in go homozygotes mice failed to
reveal any loss of any motoneurons compared to control mice
(McGeachie et al., 2001). Moreover, another study also failed to
discover any abnormalities of the motor nerve terminal Schwann
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FIGURE 6 | FGF5 regulates Schwann cell migration and adhesion. (A) Phase-contrast image of control untreated rat primary Schwann cells. (B–F) Phase-contrast
images of FGF5-treated (5 ng/ml) rat primary Schwann cells at timepoints 2, 4, 6, 8, and 10 h. (G–I) Phase-contrast images show cell viability in control and
FGF5-treated Schwann cells, stained by trypan blue. Arrows in panels (G,H) indicate dead cells. At 10 h of FGF5 treatment in panel (I), there were no dead cells
stained by trypan blue in Schwann cell clusters. Scale bar 100 µm.
cells, synaptic basal lamina, or postsynaptic membrane in go
homozygous mice (Moscoso et al., 1998). Taken together, these
results demonstrated that FGF5 is dispensable for major aspects
of the nervous system development.
While FGF5 is dispensable during nervous system
development (Moscoso et al., 1998; McGeachie et al.,
2001). McGeachie et al. (2001) showed that FGF5 mRNA
was up-regulated 50-fold in denervated muscles at 7 days
after denervation, and remained high for at least 28 days.
They carefully examined the FGF5-positive cell types
in rat skeletal muscles, showing that FGF5 mRNA and
protein were expressed in both terminal and non-terminal
Schwann cells of the skeletal muscles but not in muscle fibers
(McGeachie et al., 2001). Scarlato et al. (2001) also reported
that FGF5 is dramatically up-regulated in Schwann cells of
the peripheral nerves following axotomy, but FGF5 levels
gradually returned to normal upon the contact of regenerating
axons with Schwann cells. Cultured Schwann cells express
FGF5 and forskolin treatment elevates FGF5 expression
in cultured Schwann cells. Their study provided evidence
that axon-Schwann cell interaction regulates FGF5 levels in
Schwann cell of the peripheral nerves as the time course of
FGF5 level changes matches with the time course of axon
degeneration and regeneration (Scarlato et al., 2001), although
in vivo experiments in the go homozygous FGF5 mouse
mutant failed to reveal any differences in the measured
regeneration (Moscoso et al., 1998). Thus, an FGF5 function
in peripheral nerve regeneration has not been identified with
these studies.
Previously, Scarlato et al. (2001) reported that they could not
detect FGF5 mRNA and protein in adult intact sciatic nerves.
FGF5 is highly up-regulated following peripheral nerve injury,
therefore, FGF5 has been named as one of the injury-induced
genes (Ma et al., 2016). In contrast, McGeachie et al. (2001)
demonstrated by RT-PCR that FGF5 mRNA is expressed in
adult mouse sciatic nerve. In this study, we found that both
FGF5 mRNA and protein could be detected in intact mouse
sciatic nerve, and it is expressed by myelinating Schwann cells.
Thus, FGF5 expression in the peripheral nerves is not purely
induced by injury response.
The FGF-FGFR signaling pathways regulate important
biological processes including cell proliferation and
differentiation during development and tissue repair. Upon
binding to their high-affinity receptors, FGFs activate various
signaling cascades, of which the Ras-ERK1/2 signaling pathway
is most prominent (Ornitz and Itoh, 2015). Recently, Tian
et al. (2019) also reported that FGF5 promoted spermatogonial
stem cell proliferation via ERK and AKT activation. Previous
studies have suggested FGF5 as an autocrine regulator for
Schwann cell proliferation and survival during Wallerian
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degeneration because Schwann cells in the distal nerve express
FGFRs (Meisinger and Grothe, 1997; McGeachie et al., 2001;
Scarlato et al., 2001; Grothe et al., 2006; Furusho et al.,
2009). In this report, we showed that Schwann cells in the
distal nerve express a high level of FGFR1 and FGFR2, and
it has been reported that FGF5 could activate FGFR1 and
FGFR2 with a Kd value of approximately 1 nM (Clements
et al., 1993). This raised the possibility that FGF5 could be
an autocrine regulator of Schwann cell proliferation following
peripheral nerve injury. However, our FGF5 treatment inhibited
the basal level of ERK1/2 activity in cultured rat primary
Schwann cells, instead, it regulates Schwann cell migration
and adhesion. In addition to the ERK signaling pathway,
FGFs can activate the phosphatidylinositide 3-kinase/Akt,
phospholipase Cγ, p38, and JNK kinases, STAT1, STAT3 and
STAT5 pathways (Ornitz and Itoh, 2015). These pathways
could be activated in a cell type-dependent manner (Ornitz
and Itoh, 2015). Our results of FGF5 regulates Schwann
cell migration and adhesion indicated that FGF5 could
activate other signaling pathways in Schwann cells rather
than ERK1/2 signaling. Our findings further support the
evidence that FGFs could stimulate the proliferation of some
cells but inhibit the proliferation and promote the differentiation
of others.
In this report, we identified an FGF5 autocrine function
regulating Schwann cell migration and adhesion via the
upregulation of N-cadherin. Previous studies showed that
N-cadherin is expressed in cultured rat primary Schwann cells
(Wanner and Wood, 2002; Roberts et al., 2017), and N-cadherin
is upregulated in Schwann cells following peripheral nerve injury
(Parrinello et al., 2010; Clements et al., 2017; Roberts et al.,
2017). Studies have shown that Schwann cells in the peripheral
nerves promote the repair of multiple tissue types including
peripheral nerve gap bridging, skin wound healing and digit tip
regeneration (Johnston et al., 2016; Carr and Johnston, 2017;
Parfejevs et al., 2018; Jones et al., 2019). The injury-induced
changes not only reprogram denervated Schwann cells into a
repair cell state but also give them a highly motile phenotype. The
importance of migrating Schwann cells in tissue regeneration
is most evident in the cases of peripheral nerve transection
injuries (Parrinello et al., 2010; Cattin et al., 2015; Dun et al.,
2019). Following peripheral nerve transection injury, Schwann
cells from both nerve end migrate into the nerve gap and
form Schwann cell cords in the nerve bridge to guide axons
regeneration. This Schwann cell migration property is key to
successful peripheral nerve regeneration (Parrinello et al., 2010;
Cattin et al., 2015; Chen et al., 2019; Dun and Parkinson,
2020). During the period of migration in the nerve bridge,
Schwann cells contact each other through their long processes
and form a chain to migrate toward the middle of the nerve
bridge (Chen et al., 2019). Schwann cell migration in the nerve
bridge appears as a classic example of cell chain migration,
and this chain migration is important for the correct Schwann
cell cord formation in the nerve bridge (Aigouy et al., 2008;
Parrinello et al., 2010; Dun and Parkinson, 2015). Parrinello
et al. (2010) reported that N-cadherin is a key adhesion
molecule in Schwann cells regulating chain formation in the
nerve bridge during migration. Thus, our findings indicate
that FGF5 could regulate N-cadherin expression in migrating
Schwann cells in the nerve bridge and promote Schwann cell
chain formation.
In summary, we first systematically examined the expression
of FGF5 and FGFR1-4 expression in Schwann cells of the
mouse distal sciatic nerve and then investigated the effect of
FGF5 treatment upon cultured primary rat Schwann cells. By
microarray and mRNA sequencing data set analysis, RT-PCR,
qPCR, western blot and immunostaining studies, we show that
FGF5 is highly up-regulated in Schwann cells of the mouse
distal sciatic nerve, and its receptors FGFR1 and FGFR2 are
highly expressed in Schwann cells of the peripheral nerve both
before and after injury. Using cultured primary rat Schwann
cells, we revealed that FGF5 inhibits ERK1/2 activation but
FGF5 regulates rapid Schwann cell migration and adhesion.
Thus, FGF5 is an autocrine regulator of Schwann cell migration
and adhesion. So far, Schwann cells are the best cell type that
could be delivered into a nerve guidance conduit to promote
peripheral nerve regeneration. Currently, cell delivery requires
the use of collagen or a matrix gel to support cells inside
the nerve guidance conduit. The use of collagen or matrix gel
often decreases cell density and prevent cell-cell interaction and
communication. We believe this FGF5 property of regulating
Schwann cell adhesion could be utilized for Schwann cell
delivery to prepare better engineered neural tissue for peripheral
nerve repair.
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